Multicentre Investigation of Prognostic Factors Incorporating p16 and Tumour Infiltrating Lymphocytes for Anal Cancer After Chemoradiotherapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multicentre Investigation of Prognostic Factors Incorporating p16 and Tumour Infiltrating Lymphocytes for Anal Cancer After Chemoradiotherapy
Authors
Keywords
-
Journal
CLINICAL ONCOLOGY
Volume 33, Issue 10, Pages 638-649
Publisher
Elsevier BV
Online
2021-05-22
DOI
10.1016/j.clon.2021.04.015
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Patterns and Predictors of Relapse Following Radical Chemoradiation Therapy Delivered Using Intensity Modulated Radiation Therapy With a Simultaneous Integrated Boost in Anal Squamous Cell Carcinoma
- (2019) Rebecca Shakir et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study
- (2017) Van K Morris et al. LANCET ONCOLOGY
- Clinical relevance and implications of HPV-induced neoplasia in different anatomical locations
- (2017) Elena Sophie Prigge et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- External validation of leukocytosis and neutrophilia as a prognostic marker in anal carcinoma treated with definitive chemoradiation
- (2017) Antoine Schernberg et al. RADIOTHERAPY AND ONCOLOGY
- Peripheral Leukocytosis Is Inversely Correlated with Intratumoral CD8+ T-Cell Infiltration and Associated with Worse Outcome after Chemoradiotherapy in Anal Cancer
- (2017) Daniel Martin et al. Frontiers in Immunology
- Tumour-infiltrating lymphocyte scores effectively stratify outcomes over and above p16 post chemo-radiotherapy in anal cancer
- (2016) Duncan C Gilbert et al. BRITISH JOURNAL OF CANCER
- Biomarkers in anal cancer: from biological understanding to stratified treatment
- (2016) Christopher M Jones et al. BRITISH JOURNAL OF CANCER
- The Development of an Umbrella Trial (PLATO) to Address Radiation Therapy Dose Questions in the Locoregional Management of Squamous Cell Carcinoma of the Anus
- (2016) D. Sebag-Montefiore et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53
- (2015) D Meulendijks et al. BRITISH JOURNAL OF CANCER
- High-sensitivity human papilloma virus genotyping reveals near universal positivity in anal squamous cell carcinoma: Different implications for vaccine prevention and prognosis
- (2015) Ivona Baricevic et al. EUROPEAN JOURNAL OF CANCER
- Anal Cancer: Developing an Intensity-modulated Radiotherapy Solution for ACT2 Fractionation
- (2014) R. Muirhead et al. CLINICAL ONCOLOGY
- The rising incidence of anal cancer in England 1990-2010: a population-based study
- (2014) J. R. Wilkinson et al. Colorectal Disease
- Human papillomavirus DNA load and p16INK4aexpression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy
- (2014) Franz Rödel et al. INTERNATIONAL JOURNAL OF CANCER
- Human Papillomavirus Genotyping and p16 Expression As Prognostic Factors for Patients With American Joint Committee on Cancer Stages I to III Carcinoma of the Anal Canal
- (2014) Eva Serup-Hansen et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer
- (2013) M J Ward et al. BRITISH JOURNAL OF CANCER
- Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma
- (2013) S. Lyford-Pike et al. CANCER RESEARCH
- Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus
- (2013) E. Toh et al. Colorectal Disease
- Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial
- (2013) Roger D James et al. LANCET ONCOLOGY
- p16INK4A, p53, EGFR expression and KRAS mutation status in squamous cell cancers of the anus: Correlation with outcomes following chemo-radiotherapy
- (2013) Duncan C Gilbert et al. RADIOTHERAPY AND ONCOLOGY
- Prognostic factors for recurrence and survival in anal cancer
- (2012) Robert Glynne-Jones et al. CANCER
- Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
- (2010) K. Kian Ang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
- (2009) R. M. Simon et al. JNCI-Journal of the National Cancer Institute
- Inverse Relationship between Human Papillomavirus-16 Infection and Disruptive p53 Gene Mutations in Squamous Cell Carcinoma of the Head and Neck
- (2008) W. H. Westra et al. CLINICAL CANCER RESEARCH
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial
- (2008) C. Fakhry et al. JNCI-Journal of the National Cancer Institute
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More